News
Researchers at SKUAST have achieved India's first gene-edited sheep using CRISPR-Cas9 technology. This breakthrough in animal ...
Bharat Biotech's oral Cholera Vaccine, Hillchol, has successfully completed phase III trials, proving its effectiveness against the Ogawa and Inaba serotypes. The vaccine shows promise in tackling the ...
Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...
Hold out your hands, palms up, and move them so they are on top of each other. With a little experimentation—and perhaps a ...
Earlier this month, the House of Lords passed the Precision Breeding Act, which will enable companies such as Tropic at ...
Researchers aim to transform building facades by adding microbial life, turning lifeless walls into functional, living ...
Halia Therapeutics is a clinical-stage biopharmaceutical company developing therapies that modulate the innate immune system to treat inflammation-driven diseases. By uncovering the biology behind ...
The lag in funding extends far beyond D.E.I. initiatives, affecting almost every area of science: chemistry, computing, ...
6dOpinion
Live Science on MSNColossal's de-extinction campaign is built on a semantic house of cards with shoddy foundations — and the consequences are dire | Opinion"Dire wolves" created by Colossal Biosciences were pegged as "the first animals in history to be brought back from extinction ...
Muscimol, a GABA-A (GABAA) receptor agonist, enhances GABA's inhibitory effect on neuronal activity by activating GABAA ...
10don MSNOpinion
The Trump administration's plans to slash science funding could end up liberating researchers from the corrupting influence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results